Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Evolus, Inc. - Common Stock
(NQ:
EOLS
)
5.190
-0.470 (-8.30%)
Streaming Delayed Price
Updated: 1:37 PM EST, Mar 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Evolus, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Evolus Announces Inducement Grants for New Chief Financial Officer
September 06, 2022
From
Evolus
Via
Business Wire
Evolus Appoints Sandra Beaver as Chief Financial Officer
August 30, 2022
From
Evolus
Via
Business Wire
Evolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
August 29, 2022
From
Evolus
Via
Business Wire
Recap: Evolus Q2 Earnings
↗
August 02, 2022
Evolus (NASDAQ:EOLS) reported its Q2 earnings results on Tuesday, August 2, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Needham Is Bullish On This Botox Equivalent Aesthetics Company
↗
June 24, 2022
Via
Benzinga
Recap: Evolus Q4 Earnings
↗
March 03, 2022
Evolus (NASDAQ:EOLS) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Evolus missed...
Via
Benzinga
A Preview Of Evolus's Earnings
↗
March 02, 2022
Evolus (NASDAQ:EOLS) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
Newly Published Post Hoc Analysis Evaluates Efficacy of Jeuveau® in Adult Males Compared to BOTOX®
August 24, 2022
From
Evolus
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
↗
August 05, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
August 02, 2022
Via
Benzinga
Evolus Reports Second Quarter 2022 Results and Provides Business Update
August 02, 2022
From
Evolus
Via
Business Wire
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
↗
August 03, 2022
Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.
Via
Benzinga
Evolus's Earnings: A Preview
↗
August 01, 2022
Evolus (NASDAQ:EOLS) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Evolus will report an...
Via
Benzinga
Evolus to Report Second Quarter 2022 Results and Provide Business Update
July 19, 2022
From
Evolus
Via
Business Wire
Evolus Launches New Campaign Inspiring Consumers to “Switch Your Tox and Love Evolus Forever”
July 19, 2022
From
Evolus
Via
Business Wire
Evolus Successfully Completes Patient Enrollment in Phase II Clinical Study Evaluating “Extra-Strength” Dose of Jeuveau®
July 12, 2022
From
Evolus
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022
↗
June 23, 2022
Upgrades
Via
Benzinga
Evolus's Return On Capital Employed Overview
↗
June 10, 2022
According to data from Benzinga Pro, during Q1, Evolus's (NASDAQ:EOLS) reported sales totaled $33.91 million. Despite a 3.72% increase in earnings, the company posted a loss of $17.50 million.
Via
Benzinga
Peer-Reviewed Post Hoc Analysis Shows Jeuveau® is Highly Effective for Millennials by All Measures and at All Time Points Assessed
June 02, 2022
From
Evolus
Via
Business Wire
Evolus Celebrates Third Anniversary of the Launch of Jeuveau® in the United States
May 18, 2022
From
Evolus
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2022
↗
May 13, 2022
Upgrades
Via
Benzinga
Evolus to Participate in the H.C. Wainwright Global Investment Conference
May 11, 2022
From
Evolus
Via
Business Wire
Evolus: Q1 Earnings Insights
↗
May 10, 2022
Evolus (NASDAQ:EOLS) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Evolus beat estimated earnings by 6.06%,...
Via
Benzinga
Evolus Reports First Quarter 2022 Results and Provides Business Update
May 10, 2022
From
Evolus
Via
Business Wire
Evolus to Report First Quarter 2022 Results and Provide Business Update
April 26, 2022
From
Evolus
Via
Business Wire
Evolus Announces First Patient Enrolled in Phase II Clinical Study Evaluating “Extra-Strength” Dose of Jeuveau®
March 31, 2022
From
Evolus
Via
Business Wire
EVOLUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Evolus, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
March 29, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Evolus's Return On Capital Employed Insights
↗
March 09, 2022
According to Benzinga Pro data, during Q4, Evolus (NASDAQ:EOLS) posted sales of $34.66 million. Earnings were up 6.46%, but Evolus still reported an overall loss of $18.18 million...
Via
Benzinga
Evolus Reports Narrower Q4 Loss, CFO Retires, Reaffirms FY22 Outlook
↗
March 04, 2022
Evolus Inc's (NASDAQ: EOLS) Q4 FY21 sales increased 68% Y/Y to $34.7 million in line with interim results, beating the consensus of $33.99 million, driven...
Via
Benzinga
Earnings Scheduled For March 3, 2022
↗
March 03, 2022
Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
